ABSTRACT
INTRODUCTION

Introduction to DRP's:
Drugs are a dualistic therapeutic tool. They are intended to cure, prevent or diagnose diseases, signs or symptoms, but the shadow side is that improper use can be the cause of patient morbidity and even mortality. In general, problems related to the use of approved drugs can be summarised with the term "drug-related problems".
1
A Drug-Related Problem is an event or circumstance involving drug therapy that actually or potentially interferes with desired health outcomes. DRPs can be divided into intrinsic and extrinsic toxicity. Intrinsic toxicity is caused by the interaction of the pharmaceutical, chemical and/or pharmacological
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[21] CODEN (USA): JDDTAO characteristics of the drug itself and the human biosystem. Intrinsic toxicity is synonym for adverse drug reactions. 2 ADRs can be classified using the WHO adverse reaction terminology.
1, 3 According to this, ADRs are divided into 32 system-organ classes. Extrinsic toxicity refers to the problems caused by the handling of the drug either by the healthcare professional or by the patient. The drug is not used in the proper way a medication error has been made. Medication errors can be divided into five main classes: prescribing, transcription, dispensing, administration (including non-compliance), across settings (errors occurring on the interface between different healthcare settings -for example, between hospital and ambulatory care).
Introduction to PCNE classification of DRP'S:
 During the working conference of the Pharmaceutical Care Network Europe in January 1999, a classification scheme was constructed for drug related problems (DRPs).

The classification is part of a total set of instruments. The set consists of the classification scheme, reporting forms and cases for training or validation.
The classification system is validated and adapted regularly. 
Different versions of PCNE classification:
 PCNE
Aim
The main aim of the study is prospective screening of drug related problems in ART receiving patients at RIMS Kadapa.
Objectives of the study
The key objectives of the study include  To identify various drug related problems using various domains as per PCNE (Pharmaceutical care network Europe).

To identify the most common ART regimen causing DRP.
Methodology
Study design and study period:
Study design
It is a prospective observational study.
Study period
The present study was carried out for a period of six months (November 2015-April 2016)
Study site
The present study was conducted at Rajiv Gandhi Institute of Medical Sciences (RIMS) government general hospital at the out -patient department, Kadapa.
Source of data:
The data was collected from patient medication charts, patient medication history interview and laboratory reports.
Inclusion criteria:
 All the patients of either sex receiving ART.

All patients with co morbidities.
Exclusion criteria:
 Pediatrics

Pregnant women
Method of data collection:
Data was collection was planned as follows:
The data collection was done by using the following documents:
All the collected prescriptions were screened for drug-drug interactions using micromedex online and categorized into various types as shown in the annexure.

Annexure-4 (ADR form)
Statistical analysis:
 All the data of recruited patients was entered into Microsoft office excel spread sheet and mean was calculated for differentiating the patient's age groups and classifying patient ART regimen.

Graph pad Prism Soft ware V5.1 was used to plot the graphs regarding age groups and PCNE.
RESULTS
In order to screen various DRPs in the present study a total of 125 patients treated with different ART regimens were included from the department of ART in RIMS hospital Kadapa for a period of six months from February 2016 to July 2016. Out of 125 patients 104 members experienced DRPs, which accounts 63(60.57%) males and 41(39.42%) females.
Distribution of patients based on age group and gender:
All the patients with DRPs were classified in to different age groups based on their gender. 
Distribution of patients based on co-morbidities:
In the total of 104 cases 77 (74.03%) doesn't have any co morbidities. Tuberculosis (TB) was the most common co morbidity contributed to 27 (25.96%) patients among them 18(66.66%) are males and 9(33.33%) are females.
Distribution of patients with and without DRPS based on art regimen used (N=125):
In our study all the patients were treated with five different ART regimens. Patients experiencing DRPs during the study period was 104(83.2%) and patients without experiencing any DRPs during the study period were 21(16.8%).  As per PCNE we have assessed the outcomes suggested for 330 interventions. The acceptance rate of interventions suggested was 76.96%. In the outcome domain there are four main domains consisting of seven sub domains whereas in our study 2 outcomes were measured from in two main and two sub domains.

In these domains 254(76.96%) interventions were solved (interventions were accepted), 76(23.03%) interventions were partially solved. 
DISCUSSION
The study entitled "screening of drug related problems in HIV patients receiving anti retroviral therapy" in the ART department in a tertiary care hospital was conducted for a period of six months (february2016-july2016). A Total of 125 patients were enrolled in the study based on inclusion and exclusion criteria.
In our study gender difference was found with males having higher number of ADRs than females which was in contrast with the study done by Lieketseng J Masenyetse(2015) where females had more number of ADRs than males.
9
Patients in the age group of 29-38 years experienced more number of adverse drug reactions in the present study which was in contrast with the study done by Srikanth AB et al.(2012) where patients older the ages 38 years experienced significantly higher recurrence of ADRs compared to patients aged 30 years and less.
10
In the present study co morbid condition like tuberculosis was considered as one of the predisposing factor for ADRs which was supported by the study done by Languluri Reddenna et al.,(2013).
11
Patients taking zidovudine+ lamivudine+ neviraine(ZLN) combination had higher rates of ADRs compared to patients on Tenofovir + Lamivudine + Efavirenz(TLE). It has also been found that patients taking Tenofovir + Lamivudine + Efavirenz(TLE) experienced higher rates of ADRs compared to patients taking Tenofovir + Lamivudine+ Atazanavir/ Ritonavir(TL+Ata/Rit). It supports the previous study done by Languluri Reddenna et al.,(2013) 12 and which was in contrast with the study done by Ramanjireddy Tatiparthi et al., (2014) .
